{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,11,21]],"date-time":"2025-11-21T20:07:05Z","timestamp":1763755625639,"version":"3.45.0"},"reference-count":12,"publisher":"Oncology Nursing Society (ONS)","issue":"6","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Clinical Journal of Oncology Nursing"],"published-print":{"date-parts":[[2013,12,1]]},"DOI":"10.1188\/13.cjon.614-619","type":"journal-article","created":{"date-parts":[[2013,12,4]],"date-time":"2013-12-04T21:06:55Z","timestamp":1386191215000},"page":"614-619","source":"Crossref","is-referenced-by-count":0,"title":["Monoclonal Gammopathy of Undetermined Significance\u2014Making it Understandable to Patients"],"prefix":"10.1188","volume":"17","author":[{"given":"Pamela","family":"Rule","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jeannine M.","family":"Brant","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"1302","published-online":{"date-parts":[[2013,11,26]]},"reference":[{"key":"1","doi-asserted-by":"publisher","first-page":"28","DOI":"10.1111\/j.1365-2141.2010.08207.x","article-title":"Monoclonal gammopathy of undetermined significance: A consensus statement","volume":"150","author":"J. Berenson","year":"2010","journal-title":"British Journal of Haematology"},{"key":"2","doi-asserted-by":"publisher","first-page":"5359","DOI":"10.1182\/blood-2011-11-387324","article-title":"Familial monoclonal gammopathy of undetermined significance and multiple myeloma: Epidemiology, risk factors, and biological characteristics","volume":"119","author":"A. Greenberg","year":"2012","journal-title":"Blood"},{"key":"3","doi-asserted-by":"publisher","first-page":"609","DOI":"10.1038\/leu.2011.368","article-title":"Disparities in the prevalence, pathogenesis and progression of monoclonal gammopathy of undetermined significance and multiple myeloma between blacks and whites","volume":"26","author":"A. Greenberg","year":"2012","journal-title":"Leukemia"},{"key":"4","article-title":"Monoclonal gammopathy of undeterminated significance: Introduction and current clinical issues","volume":"24","author":"M. Klincov\u00e1","year":"2011","journal-title":"Klinick\u00e1 Onkologie"},{"key":"5","doi-asserted-by":"publisher","first-page":"5573","DOI":"10.1182\/blood-2011-01-270140","article-title":"Monoclonal gammopathy of undetermined significance (MGUS) and smoldering multiple myeloma (SMM): Novel biological insights and development of early treatment strategies","volume":"117","author":"N. Korde","year":"2011","journal-title":"Blood"},{"key":"6","first-page":"578","article-title":"Management of monoclonal gammopathy of undetermined significance (MGUS) and smoldering multiple myeloma (SMM)","volume":"25","author":"R. Kyle","year":"2011","journal-title":"Oncology"},{"key":"7","doi-asserted-by":"publisher","first-page":"1121","DOI":"10.1038\/leu.2010.60","article-title":"Monoclonal gammopathy of undetermined significance (MGUS) and smoldering (asymptomatic) multiple myeloma: IMWG consensus perspectives risk factors for progression and guidelines for monitoring and management","volume":"24","author":"R. Kyle","year":"2010","journal-title":"Leukemia"},{"issue":"1","key":"8","doi-asserted-by":"publisher","first-page":"295","DOI":"10.1182\/asheducation-2010.1.295","article-title":"Monoclonal gammopathy of undetermined significance and smoldering myeloma: New insights into pathophysiology and epidemiology","volume":"2010","author":"O. Landgren","year":"2010","journal-title":"Hematology"},{"key":"9","unstructured":"Mayo Clinic. (2013). Monoclonal gammopathy of undetermined significance. Retrieved from <a target=\"_blank\" href='http:\/\/www.mayoclinic.com\/health\/monoclonal-gammopathy\/DS00870'>http:\/\/www.mayoclinic.com\/health\/monoclonal-gammopathy\/DS00870<\/a>"},{"key":"10","doi-asserted-by":"publisher","first-page":"55","DOI":"10.1053\/j.seminhematol.2010.11.001","article-title":"Bone disease from monoclonal gammopathy of undetermined significance to multiple myeloma: Pathogenesis, interventions, and future opportunities","volume":"48","author":"A. Minter","year":"2011","journal-title":"Seminars in Hematology"},{"key":"11","doi-asserted-by":"publisher","first-page":"933","DOI":"10.4065\/mcp.2010.0337","article-title":"Prevalence of monoclonal gammopathy of undetermined significance: A systematic review","volume":"85","author":"R. Wadhera","year":"2010","journal-title":"Mayo Clinic Proceedings"},{"key":"12","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD002068","article-title":"Bisphosphonates for the relief of pain secondary to bone metastases","volume":"2","author":"R. Wong","year":"2002","journal-title":"Cochrane Database of Systematic Reviews"}],"container-title":["Clinical Journal of Oncology Nursing"],"original-title":[],"link":[{"URL":"http:\/\/ons.metapress.com\/index\/RL40T7646GUTK0U3.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,11,21]],"date-time":"2025-11-21T19:54:21Z","timestamp":1763754861000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.ons.org\/publications-research\/cjon\/17\/6\/monoclonal-gammopathy-undetermined-significance-making-it"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2013,11,26]]},"references-count":12,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2013,12,1]]}},"alternative-id":["RL40T7646GUTK0U3"],"URL":"https:\/\/doi.org\/10.1188\/13.cjon.614-619","relation":{},"ISSN":["1092-1095","1538-067X"],"issn-type":[{"type":"print","value":"1092-1095"},{"type":"electronic","value":"1538-067X"}],"subject":[],"published":{"date-parts":[[2013,11,26]]}}}